Author:
Cardigan Rebecca A,Mackie Ian J,Machin Samuel J
Reference13 articles.
1. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation;MORRISSEY;Blood,1993
2. JESKE W, HOPPENSTEADT D, FAREED J, BERMES E. Measurement of functional and immunologic levels of tissue factor pathway inhibitor. Some methodologic considerations. Blood Coag Fibrinol 6 supp 1, S73–80, 1995.
3. SALZMAN EW, HIRSCH J, MARDER VJ. Clinical use of heparin. In: Haemostasis and Thrombosis: Basic Principles and Clinical Practice. RW Colman, J Hirsh, VJ Marder, EW Salzman (eds). pp. 1584–1591, JB Lippincott, Philadelphia (1994).
4. A sensitive assay of extrinsic pathway inhibitor (EPI) in plasma and plasma fractions;SANDSET;Thromb Res,1987
5. SELIGSOHN U, OSTERUD B, RAPAPORT S. Coupled amidolytic assay for factor VII; its use with a clotting assay to determine the activity state of factor VII. Blood 52, 978–88, 1978.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献